HIM
TWST icon

Hillsdale Investment Management’s Twist Bioscience TWST Stock Holding History

Hillsdale Investment Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-77,600
Closed -$2.85M – 739
2025
Q2 		$2.85M Sell
77,600
-3,200
-4% -$111K 0.11% 245
2025
Q1 		$3.17M Buy
80,800
+2,800
+4% +$126K 0.16% 177
2024
Q4 		$3.62M Buy
78,000
+300
+0.4% +$13.6K 0.18% 161
2024
Q3 		$3.51M Buy
77,700
+100
+0.1% +$4.76K 0.27% 148
2024
Q2 		$3.82M Buy
+77,600
New +$3.16M 0.3% 115

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Hillsdale Investment Management's TWST Position: Q3 2025 in Review

Hillsdale Investment Management sold out of Twist Bioscience (TWST) in Q3 2025, closing a stake of 77,600 shares — an estimated $2.85M sold.

Hillsdale Investment Management first reported a position in TWST in Q2 2024 and held it in 5 quarters. The position peaked at $3.82M in Q2 2024. 239 funds tracked by Wall St. Rank hold TWST as of Q3 2025.

  • Hillsdale Investment Management reported no remaining Twist Bioscience position as of Q3 2025 after selling out during the quarter.
  • Hillsdale Investment Management sold 77,600 Twist Bioscience shares in Q3 2025, an estimated $2.85M.
  • Hillsdale Investment Management first reported a position in Twist Bioscience in Q2 2024 and held it in 5 quarters.
  • Hillsdale Investment Management's Twist Bioscience position peaked at $3.82M in Q2 2024.
  • 239 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2025.

Based on Hillsdale Investment Management's 13F filing for Q3 2025, filed 10 Nov 2025.